Montag A & Associates Inc Gilead Sciences, Inc. Transaction History

Montag A & Associates Inc

$2.09 Billion
Q3 2024

A detailed history of Montag A & Associates Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Montag A & Associates Inc holds 2,400 shares of GILD stock, worth $221,784. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,400

Previous 2,400 -0.0%

Holding current value

$221,784

Previous $164,000 22.56%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$71.58 - $87.29 $17,537 - $21,386	-245 Reduced 9.26%	2,400 $175,000
Q1 2023 May 11, 2023	SELL	$77.31 - $88.08 $9,663 - $11,010	-125 Reduced 4.51%	2,645 $219,000
Q4 2022 Feb 02, 2023	BUY	$62.32 - $89.47 $49,856 - $71,576	800 Added 40.61%	2,770 $237,000
Q3 2022 Nov 09, 2022	BUY	$59.54 - $68.01 $59,540 - $68,010	1,000 Added 103.09%	1,970 $122,000
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $54,950 - $62,613	970 New	970 $57,000
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $552,627 - $694,833	-8,899 Closed	0 $0
Q2 2020 Aug 04, 2020	BUY	$72.34 - $84.0 $52,374 - $60,816	724 Added 8.86%	8,899 $685,000
Q1 2020 May 06, 2020	BUY	$62.63 - $80.22 $512,000 - $655,798	8,175 New	8,175 $611,000
Q2 2019 Aug 06, 2019	SELL	$61.87 - $69.38 $204,109 - $228,884	-3,299 Closed	0 $0
Q1 2019 May 01, 2019	SELL	$62.53 - $70.05 $34,391 - $38,527	-550 Reduced 14.29%	3,299 $214,000
Q4 2018 Feb 06, 2019	SELL	$60.54 - $79.0 $365,056 - $476,370	-6,030 Reduced 61.04%	3,849 $241,000
Q3 2018 Nov 07, 2018	SELL	$71.28 - $78.92 $1.9 Million - $2.11 Million	-26,679 Reduced 72.98%	9,879 $763,000
Q2 2018 Aug 01, 2018	SELL	$64.88 - $75.68 $215,920 - $251,863	-3,328 Reduced 8.34%	36,558 $2.59 Million
Q1 2018 May 07, 2018	SELL	$72.84 - $88.8 $1.47 Million - $1.8 Million	-20,233 Reduced 33.65%	39,886 $3.01 Million
Q4 2017 Feb 09, 2018	BUY	$71.15 - $83.52 $785,211 - $921,726	11,036 Added 22.48%	60,119 $4.31 Million
Q3 2017 Nov 06, 2017	BUY	$72.11 - $85.47 $3.54 Million - $4.2 Million	49,083	49,083 $3.98 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Montag A & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Montag A & Associates Inc with notifications on news.

Account

Montag A & Associates Inc Gilead Sciences, Inc. Transaction History